•  
• Tweet
•  
•  
•        Print
•  
•        Email
•  
•         Track Keywords

“We are very pleased to enter into this strategic relationship with [CEO] Frank [Timons] and his team at Pier 88,” said David Preimesberger, Chief Financial Officer, The Doctors Company. “We deeply believe in Frank’s abilities as an investment manager and trust that he will achieve the superior investment results we are looking for in today’s volatile market. Pier 88 has the institutional heft required of enduring asset management businesses for the long term, evidenced by the high quality Board of Advisors who have also personally invested in the firm and funds.”

“We are grateful for our partnership with The Doctors Company,” Mr. Timons said. “I look forward to helping The Doctors Company grow their assets and achieve the results our investors deserve.”

Mr. Preimesberger concludes, “The culmination of Pier 88’s investment acumen, deep experience and the solidity of their business proved an ideal fit for The Doctors Company. Our 25% ownership of the firm alongside working capital and fund investment are further testament to our confidence in Pier 88.”

Founded in 2013, Pier 88 Investment Partners is an alternative asset management firm specializing in long-biased equity hedge funds utilizing both equities and convertible bonds. The firm was founded in 2013 by Frank Timons who serves as both CEO and CIO. Before starting Pier 88, Frank had several roles at Lord Abbett including: Portfolio Manager for the convertible strategy (2012 to 2013); Portfolio Manager for the large cap core and large cap value strategy (2010-2012); and Research Analyst specializing in technology companies (2007-2010). Prior to joining Lord Abbett, Frank was a Research Analyst at Robert W. Baird & Co and Senior Strategist at Sun MicroSystems (2001-2004) focusing on venture capital investments. Frank holds a B.A. and J.D. from the University of Notre Dame and an M.B.A. from the University of Chicago.